Neutrophil to lymphocyte ratio and in-hospital mortality among patients with SARS-CoV-2: A retrospective study.

AОR, аdjusted Odds Rаtiо COVID-19 ICU, Intensive Care Unit In-hospital mortality NLR NLR, Neutrophil to lymphocyte ratio RT–PCR, Reverse Transcription Polymerase Chain Reaction SARS-CoV-2 SАRS-СоV-2, severe асute resрirаtоry syndrоme соrоnаvirus 2 СI, Cоnfidenсe Intervаl СRF, Cаse Reсоrd Fоrm

Journal

Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 30 07 2022
revised: 18 09 2022
accepted: 18 09 2022
entrez: 10 10 2022
pubmed: 11 10 2022
medline: 11 10 2022
Statut: ppublish

Résumé

The goal of this study was to investigate in-hospital mortality in patients suffering from acute respiratory syndrome coronavirus 2 (SARS-CoV-2) relative to the neutrophil to lymphocyte ratio (NLR) and to determine if there are gender disparities in outcome. Between February 26 and September 8, 2020, patients having SARS-CoV-2 infection were enrolled in this retrospective cohort research, which was categorized by NLR levels ≥9 and < 9. In total, 6893 patients were involved included of whom6591 had NLR <9, and 302 had NLR ≥9. The age of most of the patients in the NLR<9 group was 50 years, on the other hand, the age of most of the NLR ≥9 group patients was between 50 and 70 years. The majority of patients in both groups were male 2211 (66.1%). The ICU admission time and mortality rate for the patients with NLR ≥9 was significantly higher compared to patients with NLR <9. Logistic regression's outcome indicated that NLR ≥9 (odds ratio (OR), 24.9; 95% confidence interval (CI): 15.5-40.0;

Identifiants

DOI: 10.1016/j.amsu.2022.104748 PMID: 36212733 PMC: PMC9525242
pubmed: 36212733
doi: 10.1016/j.amsu.2022.104748
pii: S2049-0801(22)01508-4
pmc: PMC9525242
doi:

Types de publication

Journal Article

Langues

eng

Pagination

104748

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

Nothing to disclose.

Références

Immun Inflamm Dis. 2021 Dec;9(4):1648-1655
pubmed: 34438471
J Med Virol. 2020 Oct;92(10):1733-1734
pubmed: 32242950
Cerebrovasc Dis. 2017;44(1-2):26-34
pubmed: 28419988
PLoS One. 2018 Sep 28;13(9):e0204377
pubmed: 30265703
Ann Med Surg (Lond). 2022 Jul;79:104026
pubmed: 35757308
Signal Transduct Target Ther. 2020 May 29;5(1):84
pubmed: 32467561
Crit Rev Oncol Hematol. 2013 Oct;88(1):218-30
pubmed: 23602134
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JAMA Cardiol. 2018 Jun 1;3(6):455-462
pubmed: 29801037
World J Urol. 2017 Feb;35(2):261-270
pubmed: 27255479
Allergy. 2021 Feb;76(2):533-550
pubmed: 32662525
Ann Lab Med. 2013 Mar;33(2):105-10
pubmed: 23482854
J Clin Virol. 2020 Jun;127:104346
pubmed: 32361324
Aging (Albany NY). 2020 Jul 30;12(14):13849-13859
pubmed: 32730223
J Natl Cancer Inst. 2014 May 29;106(6):dju124
pubmed: 24875653
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
BMC Res Notes. 2017 Jan 3;10(1):12
pubmed: 28057051
Am J Cardiol. 2010 Aug 15;106(4):470-6
pubmed: 20691303
Ann Epidemiol. 2019 Oct;38:11-21.e6
pubmed: 31481293
Rev Assoc Med Bras (1992). 2020 Jun;66(6):746-751
pubmed: 32696861
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Tuberk Toraks. 2017 Mar;65(1):25-31
pubmed: 28621246
J Med Virol. 2021 Oct;93(10):5880-5885
pubmed: 34101207
Am J Emerg Med. 2021 Feb;40:110-114
pubmed: 33309506
J Med Virol. 2020 Oct;92(10):2188-2192
pubmed: 32436996
Lancet Haematol. 2020 Sep;7(9):e671-e678
pubmed: 32659214
PLoS One. 2016 Jun 03;11(6):e0156511
pubmed: 27258044
J Transl Med. 2020 May 20;18(1):206
pubmed: 32434518
Eur Respir Rev. 2018 Feb 7;27(147):
pubmed: 29436405
Dis Markers. 2020 Apr 27;2020:9731854
pubmed: 32454909
Thromb Res. 2020 Aug;192:3-8
pubmed: 32407937
PLoS One. 2012;7(10):e46561
pubmed: 23049706
PLoS One. 2018 Jan 2;13(1):e0190411
pubmed: 29293605
Crit Care. 2020 Jun 5;24(1):288
pubmed: 32503668
Crit Care. 2020 Nov 16;24(1):647
pubmed: 33198786
Crit Care. 2010;14(5):R192
pubmed: 21034463
PLoS One. 2012;7(8):e42860
pubmed: 22912753
Int Immunopharmacol. 2020 Jul;84:106504
pubmed: 32304994
EJHaem. 2021 May 05;2(3):335-339
pubmed: 34226901
Int J Antimicrob Agents. 2020 Aug;56(2):106017
pubmed: 32437920

Auteurs

Maryam Salah Al-Mazedi (MS)

Dept. of Medical Laboratory Technology, Public Authority for Applied Education and Training, Kuwait.

Rajesh Rajan (R)

Department of Cardiology, Sabah Al Ahmed Cardiac Centre, Al Amiri Hospital, Kuwait City, Kuwait.

Mohammed Al-Jarallah (M)

Department of Cardiology, Sabah Al Ahmed Cardiac Centre, Al Amiri Hospital, Kuwait City, Kuwait.

Raja Dashti (R)

Department of Cardiology, Sabah Al Ahmed Cardiac Centre, Al Amiri Hospital, Kuwait City, Kuwait.

Ahmad Al Saber (A)

Department of Mathematics and Statistics, University of Strathclyde, Glasgow, G1 1XH, UK.

Jiazhu Pan (J)

Department of Mathematics and Statistics, University of Strathclyde, Glasgow, G1 1XH, UK.

Kobalava D Zhanna (KD)

Department of Internal Medicine with the Subspecialty of Cardiology and Functional Diagnostics Named After V.S. Moiseev, Institute of Medicine, Peoples' Friendship University of Russia (RUDN University), Moscow, Russian Federation.

Hassan Abdelnaby (H)

Department of Endemic and Infectious Diseases, Faculty of Medicine, Suez Canal University, Ismailia, Egypt. Department of Medicine, Division of Gastroenterology, Al Sabah Hospital, Kuwait.

Wael Aboelhassan (W)

Department of Medicine, Division of Gastroenterology, Jaber Al Ahmed Hospital, South Surra, Kuwait.

Farah Almutairi (F)

Department of Medicine, Farwaniya Hospital, Farwaniya, Kuwait.

Naser Alotaibi (N)

Department of Medicine, Al Adan Hospital, Hadiya, Kuwait.

Mohammad Al Saleh (M)

Department of Medicine, Farwaniya Hospital, Farwaniya, Kuwait.

Noor AlNasrallah (N)

Department of Medicine, Al Adan Hospital, Hadiya, Kuwait.

Bader Al-Bader (B)

Department of Medicine, Farwaniya Hospital, Farwaniya, Kuwait.

Haya Malhas (H)

Department of Emergency Medicine, Mubarak Al-Kabeer Hospital, Jabriya, Kuwait.

Maryam Ramadhan (M)

Department of Obstetrics and Gynaecology, Maternity Hospital, Shuwaikh Medical Area, Kuwait.

Peter A Brady (PA)

Department of Cardiology, Illinois Masonic Medical Center, Chicago, IL, USA.

Ibrahim Al-Zakwani (I)

Department of Pharmacology & Clinical Pharmacy, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman & Gulf Health Research, Muscat, Oman.

Parul Setiya (P)

Department of Agrometeorology, College of Agriculture, G.B.Pant University of Agriculture & Technology, Pantnagar, Uttarakhand, India.

Mohammed Abdullah (M)

Department of Infectious Diseases, Infectious Diseases Hospital, Shuwaikh Medical Area, Kuwait.

Moudhi Alroomi (M)

Department of Infectious Diseases, Infectious Diseases Hospital, Shuwaikh Medical Area, Kuwait.

Gary Tse (G)

Cardiovascular Analytics Group, Hong Kong, China; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, China.

Classifications MeSH